Jan Hendrik Schooten

Title: Jan Hendrik Schooten: Innovator in Binding Molecules

Introduction: Jan Hendrik Schooten is an inventor based in Utrecht, Netherlands. He is currently associated with Linxis B.V. and has made significant contributions to the field of binding molecules. Although he does not hold any granted patents, his work in developing innovative applications is noteworthy.

Latest Patent Applications: Jan Hendrik Schooten's latest patent applications include "Internalizing Binding Molecules." This invention relates to binding molecules that comprise at least one single variable antibody domain, specifically targeting receptors present on fibrogenic effector cells. These cells include activated hepatic stellate cells in liver fibrosis, activated interstitial fibroblasts in lung fibrosis, and others involved in various fibrotic conditions. The invention aims for cell-specific targeted delivery of anti-fibrotic substances. Additionally, it encompasses binding molecules with at least two single variable antibody domains, nucleic acids encoding these molecules, and pharmaceutical compositions for therapeutic, prophylactic, or diagnostic purposes.

Another application is "Internalizing Binding Molecules Targeting Receptors Involved in Cell Proliferation or in Cell Differentiation." This invention focuses on binding molecules targeting receptors on myofibroblasts and hepatic stellate cells. Similar to the previous application, it includes binding molecules with multiple antibody domains, nucleic acids, and pharmaceutical compositions for various medical uses.

Conclusion: Jan Hendrik Schooten is a dedicated inventor whose work in binding molecules holds promise for advancements in therapeutic applications. His innovative approaches aim to address significant medical challenges related to fibrosis and cell proliferation.